Cargando…

BDNF Therapeutic Mechanisms in Neuropsychiatric Disorders

Brain-derived neurotrophic factor (BDNF) is the most abundant neurotrophin in the adult brain and functions as both a primary neurotrophic signal and a neuromodulator. It serves essential roles in neuronal development, maintenance, transmission, and plasticity, thereby influencing aging, cognition,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bazzari, Amjad H., Bazzari, Firas H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9368938/ https://www.ncbi.nlm.nih.gov/pubmed/35955546 http://dx.doi.org/10.3390/ijms23158417

Ejemplares similares

Attitudes and Knowledge Regarding the Therapeutic Use of Cannabinoids among Community Pharmacists: A Pilot Cross-Sectional Study in Amman, Jordan
por: Bazzari, Firas H., et al.
Publicado: (2023)

BACE1 Inhibitors for Alzheimer’s Disease: The Past, Present and Any Future?
por: Bazzari, Firas H., et al.
Publicado: (2022)

Assessing Stigma towards Mental Illness in Relation to Demographics Attitudes and Past Experiences among Pharmacy Students in a Jordanian University Sample
por: Bazzari, Amjad H., et al.
Publicado: (2023)

Neuromodulators and Long-Term Synaptic Plasticity in Learning and Memory: A Steered-Glutamatergic Perspective
por: Bazzari, Amjad H., et al.
Publicado: (2019)

Chenodeoxycholic Acid Ameliorates AlCl(3)-Induced Alzheimer’s Disease Neurotoxicity and Cognitive Deterioration via Enhanced Insulin Signaling in Rats
por: Bazzari, Firas H., et al.
Publicado: (2019)

Roles and mechanisms of ankyrin-G in neuropsychiatric disorders
por: Yoon, Sehyoun, et al.
Publicado: (2022)

Therapeutic Potential of the Microbiome in the Treatment of Neuropsychiatric Disorders
por: Evrensel, Alper, et al.
Publicado: (2019)

Critical Issues in BDNF Val66Met Genetic Studies of Neuropsychiatric Disorders
por: Tsai, Shih-Jen
Publicado: (2018)

Small Molecules: Therapeutic Application in Neuropsychiatric and Neurodegenerative Disorders
por: Schiavone, Stefania, et al.
Publicado: (2018)

Therapeutic uses of oxytocin in stress-related neuropsychiatric disorders
por: Zhang, Sen, et al.
Publicado: (2023)

Soluble Epoxide Hydrolase as a Therapeutic Target for Neuropsychiatric Disorders
por: Shan, Jiajing, et al.
Publicado: (2022)

A requirement for astrocyte IP(3)R2 signaling for whisker experience-dependent depression and homeostatic upregulation in the mouse barrel cortex
por: Butcher, John B., et al.
Publicado: (2022)

Novel Therapeutic Drugs for Neuropsychiatric Disorders
por: Hashimoto, Kenji
Publicado: (2010)

Autoantibodies in Neuropsychiatric Disorders
por: Hoffmann, Carolin, et al.
Publicado: (2016)

Kynurenine Pathway of Tryptophan Metabolism in Neuropsychiatric Disorders: Pathophysiologic and Therapeutic Considerations
por: Muneer, Ather
Publicado: (2020)

Role of Oxytocin and Vasopressin in Neuropsychiatric Disorders: Therapeutic Potential of Agonists and Antagonists
por: Cid-Jofré, Valeska, et al.
Publicado: (2021)

Ethopharmacology: Primate Models of Neuropsychiatric Disorders
por: Krystal, John H.
Publicado: (1984)

Associations of BDNF/BDNF-AS SNPs with Depression, Schizophrenia, and Bipolar Disorder
por: Shkundin, Anton, et al.
Publicado: (2023)

The genetics of neuropsychiatric disorders
por: Bray, Nicholas J., et al.
Publicado: (2018)

Adenosine Receptors in Neuropsychiatric Disorders: Fine Regulators of Neurotransmission and Potential Therapeutic Targets
por: Pasquini, Silvia, et al.
Publicado: (2022)

The Histaminergic System in Neuropsychiatric Disorders
por: Cheng, Li, et al.
Publicado: (2021)

Gut Bacteria and Neuropsychiatric Disorders
por: Dicks, Leon M. T., et al.
Publicado: (2021)

Epigenetic mechanism of SETDB1 in brain: implications for neuropsychiatric disorders
por: Zhu, Yueyan, et al.
Publicado: (2020)

Neuropsychiatric manifestations of COVID-19, potential neurotropic mechanisms, and therapeutic interventions
por: Han, Ying, et al.
Publicado: (2021)

The (Poly)Pharmacology of Cannabidiol in Neurological and Neuropsychiatric Disorders: Molecular Mechanisms and Targets
por: Vitale, Rosa Maria, et al.
Publicado: (2021)

Pathophysiology and Clinical Features of Neuropsychiatric Manifestations of Thyroid Disease
por: Jurado-Flores, Marilu, et al.
Publicado: (2022)

Gut microbiome in neuropsychiatric disorders
por: MEJÍA-GRANADOS, Diana Marcela, et al.
Publicado: (2022)

Major channels involved in neuropsychiatric disorders and therapeutic perspectives
por: Imbrici, Paola, et al.
Publicado: (2013)

New horizon for the therapeutic modality of exercise on neuropsychiatric disorders
por: Kim, Chang-Ju
Publicado: (2013)

The emerging role of omega-3 fatty acids as a therapeutic option in neuropsychiatric disorders
por: Reimers, Arne, et al.
Publicado: (2019)

The Calcium/Calmodulin-Dependent Kinases II and IV as Therapeutic Targets in Neurodegenerative and Neuropsychiatric Disorders
por: Sałaciak, Kinga, et al.
Publicado: (2021)

Rapid homeostatic plasticity and neuropsychiatric therapeutics
por: Kavalali, Ege T., et al.
Publicado: (2022)

BDNF as a therapeutic candidate for cocaine use disorders
por: McGinty, Jacqueline F.
Publicado: (2022)

The Significance of NLRP Inflammasome in Neuropsychiatric Disorders
por: Shen, Yao, et al.
Publicado: (2022)

Impact of COVID-19 on Neuropsychiatric Disorders
por: Zia, Niloufar, et al.
Publicado: (2022)

The Role of Tryptophan Metabolites in Neuropsychiatric Disorders
por: Davidson, Majid, et al.
Publicado: (2022)

Pluripotent stem cells in neuropsychiatric disorders
por: Soliman, M A, et al.
Publicado: (2017)

MMPs in learning and memory and neuropsychiatric disorders
por: Beroun, Anna, et al.
Publicado: (2019)

Neuropsychiatric disturbances in atypical parkinsonian disorders
por: Belvisi, Daniele, et al.
Publicado: (2018)

Copy Number Variations in Neuropsychiatric Disorders
por: Büki, Gergely, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_0aupul4bh5jbirgunjg9inffjr